Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
26/02/2022 6:30 pm
Trying to separate three different claims about tirzepatide: that it is the right molecule, that it is the right dose, and that it does something useful.
Vivid dreams and mild headache for the first 9 days, then nothing. Textbook for this class, apparently.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Titration is slow by design and rushing it is how people end up miserable.
Anyone got a paper worth reading on this rather than a write-up of a paper?